Serum High-Mobility Group Box 1 and Heme Oxygenase-1 as Biomarkers in COVID-19 Patients at Hospital Admission
International Journal of Molecular Sciences · 24.08.2023 · 24 (17) · 13164
DOI: 10.3390/ijms241713164 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.08.2023. Verfasst von Ilijana Grigorov und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Biological Research "Siniša Stanković"-National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia. Hauptthemen laut MEDLINE: COVID-19, HMGB1 Protein. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Fund of the Republic of Serbia, COVID-19-V.I.R.U.S., Ministry of Science, Technological Development and Innovation of the Republic of Serbia.
Themen: Mobilisation
Abstract (Originalsprache)
The careful monitoring of patients with mild/moderate COVID-19 is of particular importance because of the rapid progression of complications associated with COVID-19. For prognostic reasons and for the economic management of health care resources, additional biomarkers need to be identified, and their monitoring can conceivably be performed in the early stages of the disease. In this retrospective cross-sectional study, we found that serum concentrations of high-mobility group box 1 (HMGB1) and heme oxygenase-1 (HO-1), at the time of hospital admission, could be useful biomarkers for COVID-19 management. The study included 160 randomly selected recovered patients with mild to moderate COVID-19 on admission. Compared with healthy controls, serum HMGB1 and HO-1 levels increased by 487.6 pg/mL versus 43.1 pg/mL and 1497.7 pg/mL versus 756.1 pg/mL, respectively. Serum HO-1 correlated significantly with serum HMGB1, oxidative stress parameters (malondialdehyde (MDA), the phosphatidylcholine/lysophosphatidylcholine ratio (PC/LPC), the ratio of reduced and oxidative glutathione (GSH/GSSG)), and anti-inflammatory acute phase proteins (ferritin, haptoglobin). Increased heme catabolism/hemolysis were not detected. We hypothesize that the increase in HO-1 in the early phase of COVID-19 disease is likely to have a survival benefit by providing protection against oxidative stress and inflammation, whereas the level of HMGB1 increase reflects the activity of the innate immune system and represents levels within which the disease can be kept under control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Biological Research "Siniša Stanković"-National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.
- Vinča Institute of Nuclear Sciences-National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.
- Institute of Medical Statistics and Informatic, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
- Faculty of Biology, University of Belgrade, 11000 Belgrade, Serbia.
- Center for Medical Biochemistry, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
- Institute of Pathology, School of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
ORCID-Profile: Ilijana Grigorov, Snežana Pejić, Ana Todorović, Katarina Bobić, Ivan Soldatović, Siniša Đurašević, Nebojša Jasnić, Sanja Stanković, Branislava Milenković
Förderung
- Science Fund of the Republic of Serbia
- COVID-19-V.I.R.U.S.
- Ministry of Science, Technological Development and Innovation of the Republic of Serbia
Zitieren
APA
Grigorov, I., Pejić, S., Todorović, A., Drakulić, D., Veljković, F., Vukajlović, J. M., Bobić, K., Soldatović, I., Đurašević, S., Jasnić, N., Stanković, S., Glumac, S., Mihailović-Vučinić, V., & Milenković, B. (2023). Serum High-Mobility Group Box 1 and Heme Oxygenase-1 as Biomarkers in COVID-19 Patients at Hospital Admission. International Journal of Molecular Sciences, 24(17), 13164. https://doi.org/10.3390/ijms241713164
Vancouver
Grigorov I, Pejić S, Todorović A, Drakulić D, Veljković F, Vukajlović JM, et al. Serum High-Mobility Group Box 1 and Heme Oxygenase-1 as Biomarkers in COVID-19 Patients at Hospital Admission. International Journal of Molecular Sciences. 2023;24(17):13164. doi:10.3390/ijms241713164
BibTeX
@article{Grigorov2023,
author = {Grigorov, Ilijana and Pejić, Snežana and Todorović, Ana and Drakulić, Dunja and Veljković, Filip and Vukajlović, Jadranka Miletić and Bobić, Katarina and Soldatović, Ivan and Đurašević, Siniša and Jasnić, Nebojša and Stanković, Sanja and Glumac, Sofija and Mihailović-Vučinić, Violeta and Milenković, Branislava},
title = {Serum High-Mobility Group Box 1 and Heme Oxygenase-1 as Biomarkers in COVID-19 Patients at Hospital Admission},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {17},
pages = {13164},
doi = {10.3390/ijms241713164}
}
EUVIMED